VOCLAZIDE M (30+500) TAB

VOCLAZIDE M (30+500) TAB by Voithea Healthcare is a trusted anti-diabetic combination therapy containing Gliclazide 30mg and Metformin 500mg in a prolonged-release tablet form. This dual-action formulation effectively manages blood glucose levels by enhancing insulin secretion and improving insulin sensitivity, making it ideal for patients with type 2 diabetes.

The prolonged-release mechanism ensures steady absorption for sustained glycemic control throughout the day, reducing the risk of blood sugar fluctuations. VOCLAZIDE M (30+500) TAB exemplifies Voithea Healthcare’s commitment to offering clinically advanced and patient-centric diabetic care solutions.